Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FEXU3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,594
Award facts
- Contract value 100% obligated
- $9,594.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for RINVOQ ER 30 mg tablets in a quantity of 30 units, with a ceiling value of $9,594.18. This is a firm fixed-price, non-set-aside delivery order that represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 15, 2025.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's DLA Pharmaceutical Prime Vendor contract enables it to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. This specific delivery order for RINVOQ ER, a pharmaceutical treatment, reflects the company's ongoing role in fulfilling federal medical supply needs through competitively awarded contracts with firm fixed pricing across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FEXU3?
SPE2DB25FEXU3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FEXU3 worth?
The government has obligated $9,594 on SPE2DB25FEXU3.
Is contract SPE2DB25FEXU3 an order under another contract?
Yes. SPE2DB25FEXU3 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FEXU3 competed?
The extent of competition for SPE2DB25FEXU3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award